UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,556,890 | +138.9% | 111,127 | +76.5% | 0.00% | – |
| Q2 2023 | $651,564 | -50.8% | 62,953 | -56.1% | 0.00% | – |
| Q1 2023 | $1,325,562 | +204.1% | 143,459 | +191.9% | 0.00% | – |
| Q4 2022 | $435,953 | +15.9% | 49,149 | +9.2% | 0.00% | – |
| Q3 2022 | $376,000 | -44.8% | 45,010 | -46.0% | 0.00% | – |
| Q2 2022 | $681,000 | +95.1% | 83,276 | +108.7% | 0.00% | – |
| Q1 2022 | $349,000 | +63.1% | 39,893 | +78.3% | 0.00% | – |
| Q4 2021 | $214,000 | -70.8% | 22,374 | -48.8% | 0.00% | – |
| Q3 2021 | $734,000 | -34.8% | 43,703 | -40.6% | 0.00% | – |
| Q2 2021 | $1,125,000 | +4587.5% | 73,600 | +5869.2% | 0.00% | – |
| Q1 2021 | $24,000 | -92.3% | 1,233 | -92.8% | 0.00% | – |
| Q4 2020 | $310,000 | +336.6% | 17,178 | +366.4% | 0.00% | – |
| Q3 2020 | $71,000 | -97.0% | 3,683 | -96.0% | 0.00% | -100.0% |
| Q2 2020 | $2,377,000 | +4070.2% | 91,031 | +2739.4% | 0.00% | – |
| Q1 2020 | $57,000 | -93.9% | 3,206 | -88.6% | 0.00% | – |
| Q4 2019 | $935,000 | +286.4% | 28,009 | +175.2% | 0.00% | – |
| Q3 2019 | $242,000 | +24.7% | 10,177 | +87.8% | 0.00% | – |
| Q2 2019 | $194,000 | -78.9% | 5,418 | -78.3% | 0.00% | – |
| Q1 2019 | $920,000 | +41.8% | 24,923 | +65.4% | 0.00% | – |
| Q4 2018 | $649,000 | -54.0% | 15,067 | -49.6% | 0.00% | – |
| Q3 2018 | $1,412,000 | -21.3% | 29,890 | -17.1% | 0.00% | – |
| Q2 2018 | $1,794,000 | +25.1% | 36,045 | +24.9% | 0.00% | – |
| Q1 2018 | $1,434,000 | +15.4% | 28,857 | -13.6% | 0.00% | – |
| Q4 2017 | $1,243,000 | +66.6% | 33,412 | +41.2% | 0.00% | – |
| Q3 2017 | $746,000 | – | 23,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |